22042-Uterine Cancer-NA-129

Uterine Cancer

A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy and in Combination With Anticancer Therapies in Participants With Selected Advanced Solid Tumors (INCB 123667-101)

  • Details

ClinicalTrials.gov ID: NCT05238922
Diagnosis Type: NA
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.